ENTRY       D08229                      Drug
NAME        Montelukast (INN);
            Brondilat (TN)
FORMULA     C35H36ClNO3S
EXACT_MASS  585.2104
MOL_WEIGHT  586.1832
CLASS       Anti-allergic agent
             DG01541  Cysteinyl leukotriene receptor antagonist
            Metabolizing enzyme substrate
             DG02918  CYP2C8 substrate
             DG01642  CYP2C9 substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      Same as: C07482
            ATC code: R03DC03
            Chemical structure group: DG01066
            Product (DG01066): D00529<JP/US>
EFFICACY    Antiallergic, Antiasthmatic, Leukotriene receptor antagonist
TARGET      CYSLTR1 [HSA:10800] [KO:K04322]
  PATHWAY   hsa04020(10800)  Calcium signaling pathway
            hsa04080(10800)  Neuroactive ligand-receptor interaction
METABOLISM  Enzyme: CYP2C8 [HSA:1558], CYP2C9 [HSA:1559], CYP3A4 [HSA:1576]
INTERACTION  
STR_MAP     map07034  Eicosanoids
            map07228  Eicosanoid receptor agonists/antagonists
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             R RESPIRATORY SYSTEM
              R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
               R03D OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
                R03DC Leukotriene receptor antagonists
                 R03DC03 Montelukast
                  D08229  Montelukast (INN)
            Drug groups [BR:br08330]
             Anti-allergic agent
              DG01541  Cysteinyl leukotriene receptor antagonist
               DG01066  Montelukast
                D08229  Montelukast
             Metabolizing enzyme substrate
              DG02918  CYP2C8 substrate
               DG01066  Montelukast
                D08229  Montelukast
              DG01642  CYP2C9 substrate
               DG01066  Montelukast
                D08229  Montelukast
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG01066  Montelukast
                 D08229  Montelukast
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Cysteinyl leukotriene
                CYSLTR1
                 D08229  Montelukast (INN)
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D08229
            Drug groups [BR:br08330]
             Anti-allergic agent
              DG01541  Cysteinyl leukotriene receptor antagonist
               DG01066  Montelukast
             Metabolizing enzyme substrate
              DG02918  CYP2C8 substrate
               DG01066  Montelukast
              DG01642  CYP2C9 substrate
               DG01066  Montelukast
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG01066  Montelukast
DBLINKS     CAS: 158966-92-8
            PubChem: 96024917
            ChEBI: 50730
            PDB-CCD: MTK
            LigandBox: D08229
            NIKKAJI: J870.100H
ATOM        41
            1   C1z C    28.9800  -14.8400
            2   C1x C    28.2800  -13.5800
            3   C1x C    27.5800  -14.8400
            4   C1b C    28.9800  -16.2400
            5   C1b C    30.2400  -14.1400
            6   S2a S    27.7900  -16.9400
            7   C1c C    27.7900  -18.3400
            8   C8y C    26.6000  -19.0400
            9   C1b C    28.9800  -19.0400
            10  C8x C    25.3400  -18.3400
            11  C8x C    26.6000  -20.4400
            12  C1b C    30.2400  -18.3400
            13  C8y C    24.1500  -19.0400
            14  C8x C    25.4100  -21.1400
            15  C8y C    31.4300  -18.9700
            16  C2b C    22.9600  -18.3400
            17  C8x C    24.1500  -20.4400
            18  C8y C    31.4300  -20.3700
            19  C8x C    32.6200  -18.2700
            20  C2b C    21.7000  -19.0400
            21  C8x C    32.6200  -21.0700
            22  C1d C    30.2400  -21.0700
            23  C8x C    33.8800  -18.9700
            24  C8y C    20.5100  -18.3400
            25  C8x C    33.8800  -20.3700
            26  C1a C    28.9800  -21.7700
            27  N5x N    19.3200  -19.0400
            28  C8x C    20.5100  -16.9400
            29  C8y C    18.1300  -18.3400
            30  C8x C    19.3200  -16.2400
            31  C8y C    18.1300  -16.9400
            32  C8x C    16.8700  -19.0400
            33  C8x C    16.8700  -16.2400
            34  C8y C    15.6800  -18.3400
            35  C8x C    15.6800  -16.9400
            36  X   Cl   14.4900  -19.0400
            37  C6a C    31.4300  -14.7700
            38  O6a O    32.6200  -14.0700
            39  O6a O    31.4300  -16.1700
            40  C1a C    30.9400  -22.3300
            41  O1a O    29.5400  -19.8800
BOND        45
            1     1   2 1
            2     1   3 1
            3     1   4 1
            4     1   5 1
            5     4   6 1
            6     7   6 1 #Down
            7     7   8 1
            8     7   9 1
            9     8  10 2
            10    8  11 1
            11    9  12 1
            12   10  13 1
            13   11  14 2
            14   12  15 1
            15   13  16 1
            16   13  17 2
            17   15  18 2
            18   15  19 1
            19   16  20 2
            20   18  21 1
            21   18  22 1
            22   19  23 2
            23   20  24 1
            24   21  25 2
            25   22  26 1
            26   24  27 2
            27   24  28 1
            28   27  29 1
            29   28  30 2
            30   29  31 2
            31   29  32 1
            32   31  33 1
            33   32  34 2
            34   33  35 2
            35   34  36 1
            36    2   3 1
            37   14  17 1
            38   23  25 1
            39   30  31 1
            40   34  35 1
            41    5  37 1
            42   37  38 1
            43   37  39 2
            44   22  40 1
            45   22  41 1
///
